Hello Shareholders, What a day, I think Finra thing was

New Post Public Reply Private Reply Replies (5) Message Board
Mining Global CEO Natural Treasures #1725
Hello Shareholders,

What a day, I think Finra thing was crazy but we are back up.

So to the questions.....

Are the gold transactions still on schedule?

Gold will be sold every week until October 31st, then the monies will be put towards bills, debt buyback and share buyback.


What did the lawyers report concerning the transactions-(buy back and debt reduction)? What time frame and amounts? There were approximate dates reported--any specific dates?

Debt Buyback already working on paperwork and should have that done before end of month and the 1 Billion shares will not hit the conversions and that debt will come off the books, the stock buyback will be first Friday of November no later, and Press will come out when completed.

When you buy back shares, that will reduce outstanding shares. Will it also bring down authorized shares. If no then why not? We need to get the authorized shares down as fast as the outstanding shares. Otherwise investors just see dilution on the horizon with the numbers the way they are. Is it in your plans to reduce both?

When we buy back shares that will reduce the Float only, authorized shares have to be brought down on its own, the plan is to lower the authorized to 5 billion by march 31st 2015 and to at least 7.5 Billion by December and the Float to 5 Billion, and my plan is yes to get both down.

Is your next step on the OTC to go from the pinks to the BB? What kind of vague timeline do you see with that?

To get to BB we have allot of work to do, let me focus on the open items now and getting the stock up then we can discuss that, but if I can get to what I want by March that shouldn't be a hard move.

Do you see a market crash with rising gold prices helping MNGG weather a storm since you have very little debt as it is?

Gold moves on the dollar, so MNGG will be fine if gold dropped under 1000 a ounce there would be concern, but I dont think that will happen, we will have to wait and see.

Any update on Permit status-Congress?-When possible?

Permits, are in the works, people can say that don't know me and they don't know the company but they will see and I will show all the proof needed, but also don't want any new problems with random phone calls with no proof. So lets say by the end of the month we will have a good picture of what is going to happen.

In the last share structure update, was the 100 million shares for the media company included? When do you expect them to start? When will there 2 year no sell policy start?

I have 2 companies one for 200 million and one for 300 million, one is for awareness and another is a mining small cap group to put new eyes on this one, so they have started and will do a PR release when it is ready to go out.

Is their a particular reason the videos of the mines can not be viewed on YouTube now?

This was a information piece to show that it is real, and now its being used against me and I was encouraged to take it down until we have all of our paperwork in order then I will put it back up.

Will any of the buy backs, new PR firm, Debt payments get any press for new investors to see what is going on?

Every move that is done, A PR will be done, I always try to keep everyone in the loop.

Thank you for all the questions and I hope this helps.

But FYI, we have big things coming and this will take off soon.

Have a great weekend.

CEO

Mining Global Inc. (MNGG) Stock Research Links

MNGG Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 65

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Worldline Crowned as 2026 SPARK Matrix Leader

Updated Category News Views 68

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 50

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Class Action Lawsuit Hits Honor GMC & Hummer Hard

Updated Category News Views 35

Digging into the Allegations Against Honor GMC & Hummer Well, it looks like Honor GMC & Hummer is in hot water this week. The Zakay Law Group, a San Diego-based legal firm, has filed a class action complaint against the dealership giant, claiming they've been cutting corners where it matters most—paying their workers. What's the Beef? The suit levels some hefty...

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 69

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Flagstar Faces Heat: 9.2% Stock Drop Spurs Probe

Updated Category News Views 76

Flagstar's Descent: What Led to the Stock Tumble? And here we go again with a big name in finance taking a hit right between the eyes. Flagstar Bank, under ticker NYSE:FLG, saw its shares plummet by over 9.2% on October 23, 2026. This isn't just a blip—it's a spill. The backdrop here is an eye-watering $12.9 billion loan book tied to rent-regulated apartment buildings....

Continue Reading
Webull Faces Investor Lawsuit: Compliance in Question

Updated Category News Views 130

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

Continue Reading
Japanese Hair Care Brand &honey Garners Top U.S. Award

Updated Category News Views 79

Hydration Reigns in Hair Care Here's something that'll make your average shampoo tremble in its plastic boots: Japan's &honey Deep Moist Shampoo has snagged the spot as Best Drugstore Shampoo for 2026, according to the Marie Claire Beauty Awards. It’s not some trivial title, folks. In a market flooded with every hair-elixir promise under the sun, getting this nod is...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 0

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Vanda's NEREUS Outperforms in GLP-1 Vomiting Study

Updated Category News Views 32

A Surprising Breakthrough in Vomiting Prevention You don't need to be an old hand on Wall Street to see that when a biotech company rolls out positive trial results, ears perk up. Today, Vanda Pharmaceuticals' announcement that their NEREUS™ (tradipitant) drug aced Study 3601 is catching more eyes than initially expected. It's not just about hitting numbers; it's about...

Continue Reading

Top 5 Most Recently Viewed Articles

Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 184

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading
ARGAN Reports Major Carbon Emission Reductions in 2025

Updated Category News Views 323

Embracing Sustainability: ARGAN's 2025 ESG Report Highlights ARGAN, a leader in the development and rental of premium warehouses, has recently published its 2025 ESG report, showcasing remarkable achievements in sustainability and environmental stewardship. The report outlines a significant 25% reduction in CO2 emissions associated with energy consumption in their...

Continue Reading
Feedonomics Enhances YouTube Shopping With Strategic Partnership

Updated Category News Views 55

Feedonomics Partners with YouTube for Shopping Program Feedonomics has announced an exciting new partnership with YouTube that aims to boost the YouTube Shopping affiliate program. This collaboration focuses on providing robust product listing services and data optimization for merchants who participate in this rapidly growing online shopping platform. Streamlining...

Continue Reading
BJ's Wholesale Club Achieves Record High Stock Value of $92.38

Updated Category News Views 89

BJ's Wholesale Club Stock Breaks Records In an impressive show of market confidence, BJ's Wholesale Club Holdings Inc (NYSE: BJ) has celebrated a remarkable achievement as its stock surged to an all-time high, reaching a price of $92.38. This remarkable progression highlights the company’s ongoing growth and a substantial yearly change of 39.83% in stock price....

Continue Reading
Conduent's Upcoming Earnings: What Investors Should Know

Updated Category News Views 133

Conduent's Earnings Announcement Insights Conduent (NASDAQ: CNDT) will be sharing its quarterly earnings report soon. This announcement is essential for investors who are keen to understand the company's performance in detail. What Analysts Expect Analysts are currently estimating an earnings per share (EPS) of $-0.07 for Conduent. These figures are formulated based on...

Continue Reading